| The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis ZM Younossi, P Golabi, L de Avila, JM Paik, M Srishord, N Fukui, Y Qiu, ... Journal of hepatology 71 (4), 793-801, 2019 | 1693 | 2019 |
| Changes in the global burden of chronic liver diseases from 2012 to 2017: the growing impact of NAFLD JM Paik, P Golabi, Y Younossi, A Mishra, ZM Younossi Hepatology 72 (5), 1605-1616, 2020 | 566 | 2020 |
| The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review ZM Younossi, P Golabi, JM Paik, A Henry, C Van Dongen, L Henry Hepatology 77 (4), 1335-1347, 2023 | 564 | 2023 |
| Mortality related to nonalcoholic fatty liver disease is increasing in the United States JM Paik, L Henry, L De Avila, E Younossi, A Racila, ZM Younossi Hepatology Communications 3 (11), 1459-1471, 2019 | 190 | 2019 |
| Burden of non-alcoholic fatty liver disease in Asia, the Middle East and North Africa: Data from Global Burden of Disease 2009-2019 P Golabi, JM Paik, S AlQahtani, Y Younossi, G Tuncer, ZM Younossi Journal of hepatology 75 (4), 795-809, 2021 | 119 | 2021 |
| the epidemiologic burden of non‐alcoholic fatty liver disease across the world L Henry, J Paik, ZM Younossi Alimentary pharmacology & therapeutics 56 (6), 942-956, 2022 | 112 | 2022 |
| Are there outcome differences between NAFLD and metabolic‐associated fatty liver disease? ZM Younossi, JM Paik, R Al Shabeeb, P Golabi, I Younossi, L Henry Hepatology 76 (5), 1423-1437, 2022 | 104 | 2022 |
| Global burden of NAFLD and chronic liver disease among adolescents and young adults JM Paik, K Kabbara, KE Eberly, Y Younossi, L Henry, ZM Younossi Hepatology 75 (5), 1204-1217, 2022 | 102 | 2022 |
| Patients with lean nonalcoholic fatty liver disease are metabolically abnormal and have a higher risk for mortality P Golabi, J Paik, N Fukui, CT Locklear, L de Avilla, ZM Younossi Clinical diabetes 37 (1), 65-72, 2019 | 100 | 2019 |
| Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States P Golabi, J Paik, R Reddy, E Bugianesi, G Trimble, ZM Younossi BMC gastroenterology 19, 1-8, 2019 | 98 | 2019 |
| Contribution of sarcopenia and physical inactivity to mortality in people with non-alcoholic fatty liver disease P Golabi, L Gerber, JM Paik, R Deshpande, L de Avila, ZM Younossi JHEP Reports 2 (6), 100171, 2020 | 79 | 2020 |
| The growing burden of disability related to nonalcoholic fatty liver disease: data from the global burden of disease 2007‐2017 JM Paik, P Golabi, Y Younossi, M Srishord, A Mishra, ZM Younossi Hepatology communications 4 (12), 1769-1780, 2020 | 71 | 2020 |
| Mortality of NAFLD according to the body composition and presence of metabolic abnormalities P Golabi, JM Paik, T Arshad, Y Younossi, A Mishra, ZM Younossi Hepatology communications 4 (8), 1136-1148, 2020 | 70 | 2020 |
| Poor awareness of liver disease among adults with NAFLD in the United States SA Alqahtani, JM Paik, R Biswas, T Arshad, L Henry, ZM Younossi Hepatology Communications 5 (11), 1833-1847, 2021 | 68 | 2021 |
| Prevalence of nonalcoholic fatty liver disease in the female population T Arshad, P Golabi, J Paik, A Mishra, ZM Younossi Hepatology communications 3 (1), 74-83, 2019 | 61 | 2019 |
| Nonalcoholic fatty liver disease and alcoholic liver disease are major drivers of liver mortality in the United States JM Paik, P Golabi, R Biswas, S Alqahtani, C Venkatesan, ZM Younossi Hepatology communications 4 (6), 890-903, 2020 | 57 | 2020 |
| Prevalence and outcomes of non‐alcoholic fatty liver disease (NAFLD) among Asian American adults in the United States P Golabi, J Paik, JP Hwang, S Wang, HM Lee, ZM Younossi Liver International 39 (4), 748-757, 2019 | 57 | 2019 |
| Among Medicare patients with hepatocellular carcinoma, non–alcoholic fatty liver disease is the most common etiology and cause of mortality D Hester, P Golabi, J Paik, I Younossi, A Mishra, ZM Younossi Journal of Clinical Gastroenterology 54 (5), 459-467, 2020 | 53 | 2020 |
| Nonalcoholic Fatty Liver Disease Prevalence Trends Among Adolescents and Young Adults in the U nited S tates, 2007‐2016 T Arshad, JM Paik, R Biswas, SA Alqahtani, L Henry, ZM Younossi Hepatology Communications 5 (10), 1676-1688, 2021 | 46 | 2021 |
| Mortality risk detected by atherosclerotic cardiovascular disease score in patients with nonalcoholic fatty liver disease P Golabi, N Fukui, J Paik, M Sayiner, A Mishra, ZM Younossi Hepatology communications 3 (8), 1050-1060, 2019 | 44 | 2019 |
Zobair YounossiThe Global NASH CouncilVerified email at cldq.org
